###begin article-title 0
###xml 20 25 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
###xml 8 13 <span type="species:ncbi:9606">human</span>
A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1)
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 112 119 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</sup>
###xml 258 263 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
###xml 419 422 409 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N a</bold>
###xml 427 428 417 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 445 449 435 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10 p</bold>
###xml 776 785 766 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 789 796 779 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 361 366 <span type="species:ncbi:4932">yeast</span>
###xml 618 624 <span type="species:ncbi:9606">humans</span>
Protein acetylation is among the most common protein modifications. The two major types are post-translational Nepsilon-lysine acetylation catalyzed by KATs (Lysine acetyltransferases, previously named HATs (histone acetyltransferases) and co-translational Nalpha-terminal acetylation catalyzed by NATs (N-terminal acetyltransferases). The major NAT complex in yeast, NatA, is composed of the catalytic subunit Naa10p (N alpha acetyltransferase 10 protein) (Ard1p) and the auxiliary subunit Naa15p (Nat1p). The NatA complex potentially acetylates Ser-, Ala-, Thr-, Gly-, Val- and Cys- N-termini after Met-cleavage. In humans, the homologues hNaa15p (hNat1) and hNaa10p (hArd1) were demonstrated to form a stable ribosome associated NAT complex acetylating NatA type N-termini in vitro and in vivo.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 534 542 534 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 626 631 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
###xml 655 661 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 755 760 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 785 791 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 690 695 <span type="species:ncbi:9606">human</span>
###xml 855 860 <span type="species:ncbi:9606">human</span>
We here describe a novel human protein, hNaa16p (hNat2), with 70% sequence identity to hNaa15p (hNat1). The gene encoding hNaa16p originates from an early vertebrate duplication event from the common ancestor of hNAA15 and hNAA16. Immunoprecipitation coupled to mass spectrometry identified both endogenous hNaa15p and hNaa16p as distinct interaction partners of hNaa10p in HEK293 cells, thus demonstrating the presence of both hNaa15p-hNaa10p and hNaa16p-hNaa10p complexes. The hNaa16p-hNaa10p complex acetylates NatA type N-termini in vitro. hNaa16p is ribosome associated, supporting its potential role in cotranslational Nalpha-terminal acetylation. hNAA16 is expressed in a variety of human cell lines, but is generally less abundant as compared to hNAA15. Specific knockdown of hNAA16 induces cell death, suggesting an essential role for hNaa16p in human cells.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 36 41 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
###xml 154 159 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
###xml 81 86 <span type="species:ncbi:9606">human</span>
At least two distinct NatA protein Nalpha-terminal acetyltransferases coexist in human cells potentially creating a more complex and flexible system for Nalpha-terminal acetylation as compared to lower eukaryotes.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 897 898 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 914 920 914 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 925 931 925 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 988 990 988 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1046 1047 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1166 1167 1166 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1359 1361 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1362 1364 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1415 1423 1415 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1427 1436 1427 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1491 1492 1491 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1505 1511 1505 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 1557 1563 1557 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 1641 1643 1641 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1821 1823 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 2104 2110 2104 2110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 2114 2120 2114 2120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 2181 2183 2181 2183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2184 2186 2184 2186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2254 2256 2254 2256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2443 2445 2443 2445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 47 52 <span type="species:ncbi:4932">yeast</span>
###xml 248 253 <span type="species:ncbi:4932">yeast</span>
###xml 772 777 <span type="species:ncbi:4932">yeast</span>
###xml 1174 1179 <span type="species:ncbi:9606">human</span>
###xml 1251 1256 <span type="species:ncbi:9606">human</span>
###xml 1283 1288 <span type="species:ncbi:9606">human</span>
###xml 1307 1312 <span type="species:ncbi:4932">yeast</span>
###xml 1471 1476 <span type="species:ncbi:4932">yeast</span>
###xml 1499 1504 <span type="species:ncbi:4932">yeast</span>
###xml 1545 1551 <span type="species:ncbi:9606">humans</span>
###xml 1766 1771 <span type="species:ncbi:9606">human</span>
###xml 2163 2168 <span type="species:ncbi:9606">human</span>
About 80% of all mammalian proteins and 50% of yeast proteins are estimated to be cotranslationally acetylated at their N-termini [1-6]. This clearly makes N-terminal acetylation one of the most common protein modifications in eukaryotic cells. In yeast, three complexes, NatA, NatB and NatC, express different substrate specificities and are responsible for the majority of N-terminal acetylation [6]. At present, the nomenclature of this class of enzymes is not coherent and later this year a revised nomenclature of this enzyme class will be presented (Polevoda B, Arnesen T and Sherman F, unpublished). In brief, for the proteins mentioned in this study the following names will apply: Naa10p (Ard1), Naa11p (Ard2), Naa15p (Nat1), Naa16p (Nat2) and Naa50p (Nat5). The yeast NatA complex contains the structural subunit Naa15p mediating ribosome association and the catalytic subunit Naa10p [7,8]. Deletion of yNAA15 and yNAA10 results in a number of common defects including lack of Go entry, reduced cell growth, and inability to sporulate [9-11]. The subunit Naa50p is also physically associated with Naa10p and Naa15p, but the function of hNaa50p is unknown [7]. The human NatA, NatB and NatC complexes were recently characterized [12-15]. The human NatA complex contains the human homologues of the yeast NatA components hNaa10p, hNaa15p and hNaa50p [13,16]. The function and substrate specificity of hNatA in vivo and in vitro were found to resemble that of the yeast NatA complex [1]. The yeast NAA10 gene is duplicated in mammals. In humans, the NAA10 duplication has lead to the generation of a novel protein designated hNaa11p [17]. Similarly to hNaa10p, hNaa11p potentially interacts with hNaa15p implying that two distinct NatA complexes may exist in human cells: both hNaa15p-hNaa10p and hNaa15p-hNaa11p [17]. However, an endogenous hNaa15p-hNaa11p complex has not yet been detected, thus the functional importance of hNaa11p remains to be elucidated. hNaa10p and hNaa15p were previously demonstrated to be important for normal cellular viability. RNA interference-mediated knockdown of hNAA10 or hNAA15 induced apoptosis and cell cycle arrest in human cell lines [18-20], thus hNaa10p has been proposed to be a novel cancer drug target [21]. On the other hand, it has also been reported that hNaa10p is essential for the induction of apoptosis since knockdown of hNaa10p protected cells against doxorubicin induced apoptosis [22].
###end p 9
###begin p 10
###xml 332 338 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 399 405 399 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 308 313 <span type="species:ncbi:9606">human</span>
###xml 380 385 <span type="species:ncbi:4932">yeast</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 539 544 <span type="species:ncbi:9606">human</span>
In order to identify novel interaction partners of hNaa10p, we performed immunoprecipitation of hNaa10p from HEK293 cells, followed by trypsin digestion of immunoprecipitated proteins and peptide analysis by mass spectrometry. We here demonstrate the existence of an endogenous hNaa16p protein, encoded by a human paralogue of the hNAA15 gene representing a new orthologue of the yeast NAA15 gene. hNAA16 mRNA is generally expressed in human cells. The hNaa16p protein associates with ribosomes, and interacts with hNaa10p to form a novel human NatA complex.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Identification of hNaa16p and the hNaa16p-hNaa10p complex
###end title 12
###begin p 13
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 773 774 773 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 935 936 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 988 989 988 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1093 1095 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1191 1192 1191 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1257 1259 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1801 1802 1801 1802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1883 1884 1883 1884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
We used an immunoprecipitation-mass spectrometry approach to identify novel interaction partners of hNaa10p. Endogenous hNaa10p was collected from HEK293 cell extracts using a hNaa10p-specific antibody. The immunoprecipitates were analysed by LC/MS/MS after trypsin digestion. In addition to hNaa10p, hNaa15p and hNaa50p [13,16], we identified a novel protein, hNaa16p (hNat2/Entrez gene official symbol: NARG1L), in each of four parallel affinity extractions obtained using anti-hNaa10p. Both hNaa15p and hNaa16p were identified by several unique peptides. Neither hNaa10p nor hNaa15p nor hNaa16p were present in four negative controls using unspecific immunoglobulins. The identified hNaa15p and hNaa16p specific peptides are presented in Figure 1 and in Additional File 1. The MS/MS spectra of two of these peptides, RAIELATTLDESLTNR (uniquely identifying hNaa15p) and DLESFNEDFLK (uniquely identifying hNaa16p) are shown in Figure 2. From the alignments (Figure 1 and Additional File 2) it is obvious that the two proteins hNaa15p and hNaa16p are highly similar. According to NCBI bl2seq [23], hNaa15p and hNaa16p share 70% identity and 85% similarity at the amino acid level. In Figure 3, hNaa15p and hNaa16p structural domains as identified by SMART [24] are presented. Both proteins contain several Tetratricopeptide (TPR) domains which are degenerate 34 amino acids repeats containing a helix-loop-helix presumed to be involved in protein-protein interactions. hNaa15p is predicted to contain 4 TPRs while hNaa16p is predicted to have 5 TPRs. This difference results from program threshold values chosen, and since both proteins are highly similar in this region, it is likely that also hNaa15p may have a fifth TPR domain in the same region. Both proteins contain coiled-coil domains (Figure 3). Also the exon-intron organisation for the two genes is highly similar (Figure 3).
###end p 13
###begin p 14
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of hNaa15p and hNaa16p proteins with identified peptides from anti-hNaa10p affinity extracts indicated</bold>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
Alignment of hNaa15p and hNaa16p proteins with identified peptides from anti-hNaa10p affinity extracts indicated. Sequences for hNaa15p and hNaa16p were aligned using Muscle [36], with sequences common to both proteins shown between the hNaa15p and hNaa16p sequences. Tryptic peptides uniquely identifying hNaa15p are in bold and red, sequences uniquely identifying hNaa16p are in bold and green, and peptides common to both proteins are bold and black. Breaks indicate two different peptides within a region. A number of peptides unique to each protein confirmed that hNaa16p has a different sequence from hNaa15p.
###end p 14
###begin p 15
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MS/MS spectra of peptides uniquely identifying hNaa15p and hNaa16p in complex with hNaa10p</bold>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
MS/MS spectra of peptides uniquely identifying hNaa15p and hNaa16p in complex with hNaa10p. A. MS/MS spectrum of the peptide RAIELATTLDESLTNR, which uniquely identifies hNaa15p in the hNaa10p affinity extraction. The MS/MS spectrum of the +2 peptide ion was matched to this sequence with an Xcorr of 4.25 [30]; the peptide had a probability of correct sequencing of 0.99 [32]. B. MS/MS spectrum of the peptide DLESFNEDFLK, which uniquely identifies hNaa16p in the hNaa10p affinity extraction. The MS/MS spectrum of the +2 peptide ion was matched to this sequence with an Xcorr of 3.4; the peptide had a probability of correct sequencing of 0.95. All fragment ions have a +1 charge. Individual matched y ions (blue) and b ions (red) are indicated in bold; the position of the peptide precursor ion is indicated by the dagger; the x-axis units are m/z and the y-axis represents relative peak intensity normalized to the most intense fragment ion.
###end p 15
###begin p 16
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overview of structural domains and exon structure of hNaa15p and hNaa16p</bold>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Overview of structural domains and exon structure of hNaa15p and hNaa16p. SMART analysis [24] demonstrates the presence of TPR domains (yellow) and coiled coil regions (green). Intron positions are indicated with vertical lines showing the intron phase (below lines) and exact amino acid position (above lines).
###end p 16
###begin p 17
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1521 1523 1521 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1250 1255 <span type="species:ncbi:9606">human</span>
The interaction between hNaa16p and hNaa10p appears to be independent of the hNaa15p-hNaa10p complex since hNaa16p-specific peptides were not present in anti-hNaa15p immunoprecipitates analysed in parallel. Since both hNaa15p and hNaa16p interact with hNaa10p, it is of interest to determine the approximate ratio of hNaa15p versus hNaa16p in complex with hNaa10p. To make a rough and qualitative estimate of the amounts of hNaa15p and hNaa16p complexed with hNaa10p, the protein abundance index [25] was calculated for each protein as the number of LC/MS/MS-observed tryptic peptides (unique to each protein) divided by the total number of tryptic peptides that could be identified by SEQUEST under the exact search conditions used. For hNaa15p, this number was 0.0858, while for hNaa16p it was 0.0138. hNaa15p-hNaa10p complexes thus appear to be roughly 6-fold more abundant than hNaa16p-hNaa10p complexes in HEK293 cells. As an additional verification of the hNaa16p-hNaa10p interaction, we expressed tagged hNaa16p-FLAG and hNaa10p-V5 in HeLa cells and demonstrated that hNaa16p-FLAG was co-immunoprecipitated with hNaa10p-V5 (Figure 4A). In conclusion, these observations clearly support the presence of an endogenous hNaa16p-hNaa10p complex in human cells. Furthermore, we also wanted to test whether hNaa16p could interact with hNaa11p, since the latter protein is very similar to hNaa10p. The co-immunoprecipitation experiments using hNaa16p-FLAG and hNaa11p-V5, demonstrated that this indeed is the case (Figure 4B).
###end p 17
###begin p 18
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">hNaa10p-V5 and hNaa11p-V5 co-immunoprecipitate hNaa16p-FLAG</bold>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10</italic>
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA11</italic>
###xml 562 567 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
hNaa10p-V5 and hNaa11p-V5 co-immunoprecipitate hNaa16p-FLAG. (A) HeLa cells were transfected with phNAA10-V5 and phNAA16-FLAG as indicated and the cell lysates were immunoprecipitated (IP) with anti-V5 or unspecific control antibodies. The immunoprecipitates and lysate controls were analyzed by SDS-PAGE and Western blotting using anti-FLAG and anti-V5 antibodies. The amount of the lysate loaded on the gel represents approximately 20% of the material used for IP. Results are representative of three independent experiments. (B) As (A) using phNAA11-V5 and phNAA16-FLAG plasmids.
###end p 18
###begin title 19
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
Expression of hNAA15 and hNAA16 in human cell lines
###end title 19
###begin p 20
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 462 468 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 586 592 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 783 789 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 835 841 835 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1293 1299 1293 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 1304 1310 1304 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1335 1341 1335 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 1389 1395 1389 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1520 1526 1520 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1608 1614 1608 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 1710 1712 1710 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1713 1715 1713 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1769 1775 1769 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 2090 2092 2090 2092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 2175 2181 2175 2181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
To investigate the expression of these two human homologues of the yeast NAA15 gene, we analysed the expression of hNAA15 and hNAA16 mRNA by quantitative RT-PCR in 10 human cell lines of various origin (Figure 5A) and 10 human cell lines originating from the thyroid gland (Figure 5B). Both genes are highly expressed in HepG2 (hepatocellular carcinoma), HEK293 (kidney adenocarcinoma), and SK-MEL2 (malignant melanoma) cell lines. Our results demonstrate that hNAA16 is expressed in all cell lines analyzed, and hNAA15 is the most abundant species of the two. The expression level of hNAA15 mRNA is 2-3 times than that of hNAA16 mRNA in cell lines like TAD-2 and HepG2, while it is 7-11 times more abundant in GaMG, SK-N-MC, HeLa, and B-CPAP cells. Interestingly, in HEK293 cells, hNAA15 mRNA is 5 times more abundant as compared to hNAA16 mRNA. Although there is not necessarily a direct relationship between the level of a specific mRNA and the level of the corresponding protein, this agrees with our rough estimates that hNaa15p-hNaa10p complexes appear to be 6-fold more abundant than hNaa16p-hNaa10p complexes in HEK293 cells, thus suggesting that the level of the various NatA complexes present is proportional to the presence of their single subunits. Tissue expression profiles for hNAA15 and hNAA16 mRNA also indicate that hNAA15 mRNA is generally more abundant as compared to hNAA16 (NCBI-UNIGENE-EST PROFILE VIEWER). However, in certain tissues like adrenal gland, mammary gland, heart, testis and thymus, hNAA16 appears to be the dominant species ( and ). Previously, it was demonstrated that hNAA15 was overexpressed in papillary thyroid carcinomas as compared to non-neoplastic thyroid tissue [26,27]. The current data support these observations since hNAA15 is slightly or significantly overexpressed in all types of thyroid cancer cell lines tested as compared to the primary thyroid cells (TAD-2/Nthy ori 3.1): follicular thyroid carcinoma (CGTH-W-1), papillary thyroid carcinoma (NPA/B-CPAP/ONCO-DG-1/BHT-101) and anaplastic thyroid carcinoma (8305C/CAL-62/ARO) (Figure 5B). On the other hand, we are not able to make similar conclusions with respect to hNAA16 which appears to be expressed equally in tumour- and non-tumour thyroid cell lines.
###end p 20
###begin p 21
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of h<italic>NAA15 </italic>and h<italic>NAA16 </italic>in human cell lines</bold>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 780 785 <span type="species:ncbi:9606">human</span>
###xml 861 866 <span type="species:ncbi:9606">human</span>
Expression of hNAA15 and hNAA16 in human cell lines. (A) The expression of hNAA15 and hNAA16 mRNA in 10 different human cell lines was analysed by real-time quantitative PCR (RT-qPCR) using gene specific primers. Values were normalized to the expression of RpLP2. An independent normalization was performed using a second reference gene, RPol2, producing almost identical results (data not shown). The mean +/- SD of triplicate experiments was calculated. HepG2, hepatocellular carcinoma; HEK293, kidney adenocarcinoma; HCT116, colon carcinoma; A431, epidermoid carcinoma; SK-MEL-2, malignant melanoma; NCI-H1299, non-small cell lung carcinoma; GaMG, glioblastoma; SK-N-MC, neuroepithelioma; MCF7, breast adenocarcinoma; HeLa, cervix adenocarcinoma. (B) As (A) using 10 different human cell lines originating from the thyroid gland. TAD-2/Nthy ori 3.1, primary human thyroid cells; CGHT-W-1, follicular thyroid carcinoma; NPA/B-CPAP/ONCO-DG-1/BHT-101, papillary thyroid carcinoma; 8305C/CAL-62/ARO, anaplastic thyroid carcinoma.
###end p 21
###begin title 22
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
Evolution of the hNAA16 gene
###end title 22
###begin p 23
###xml 5 11 5 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NARG1</italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NARG1L</italic>
###xml 252 276 252 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 278 300 278 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 302 345 302 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis, Drosophila melanogaster</italic>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 561 567 561 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona</italic>
###xml 786 792 786 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 809 819 809 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 888 894 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 929 935 929 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1021 1027 1021 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 1032 1037 1032 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA11</italic>
###xml 1143 1145 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 252 276 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 278 300 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 302 320 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 322 345 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 838 847 <span type="species:ncbi:7955">zebrafish</span>
The hNAA15 gene (Entrez gene official symbol: NARG1) is located to chromosome 4 (4q31.1) while the hNAA16 gene (Entrez gene official symbol: NARG1L) is located to chromosome 13 (13q14.11). hNaa15p and hNaa16p belong to a protein family with members in Saccharomyces cerevisiae, Caenorhabditis elegans, Ciona intestinalis, Drosophila melanogaster, fish, frog and several higher mammals (Family ENSF00000002142 from Ensembl v38, April 2006 [see methods]). The phylogenetic tree of this family (Figure 6) suggests that the duplication that resulted in hNAA15 and hNAA16 occurred at some point after the speciation that resulted in the higher chordates (i.e. after the divergence of Ciona), but before the speciation of mammals into eutheria and metatheria. The exact timing is confused by Ciona branching before Drosophila, and by the fish (zebrafish, fugu, tetraodon) appearing in only the NAA15 clade (possibly suggesting loss of NAA16 in fish). The duplication therefore occurred before the duplication that resulted in hNAA10 and hNAA11, which we previously narrowed down to some time shortly after the divergence of eutheria and metatheria [17].
###end p 23
###begin p 24
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phylogenetic tree of <italic>NAA15 </italic>genes</bold>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
Phylogenetic tree of NAA15 genes. A phylogenetic tree showing that the duplication leading to hNAA15 and hNAA16 occurred at some point after the divergence of Ciona from the other chordates, and before the speciation that resulted in the amphibia. This is before the duplication resulting in the NAA10s [17]. All identifiers are from Ensembl. Branches highlighted with a black dot are those where the probability of the split represented by the branch is > 0.95. Probable NAA15 and NAA16 clades are indicated. In-paralogues in this tree represent alternative transcripts, which are possibly artefacts of the genome annotation. See Methods for details.
###end p 24
###begin p 25
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona</italic>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 156 165 <span type="species:ncbi:7955">zebrafish</span>
###xml 170 175 <span type="species:ncbi:4932">yeast</span>
###xml 203 208 <span type="species:ncbi:4932">yeast</span>
###xml 328 337 <span type="species:ncbi:7955">zebrafish</span>
Additional File 2 presents an alignment of hNaa15p and hNaa16p protein sequences from human, mouse, and opossum, together with their homologues from Ciona, zebrafish and yeast. With the exception of the yeast protein, the sequences are highly similar until approximately 100 residues from their C-termini. The similarity of the zebrafish protein to the Naa15ps rather than the Naa16ps is obvious from the alignment.
###end p 25
###begin title 26
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
hNaa16p associates with ribosomes and hNaa16p-hNaa10p acetylates NatA-type N-termini in vitro
###end title 26
###begin p 27
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 446 451 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
###xml 571 580 567 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 808 817 804 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 974 975 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1008 1017 1004 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1025 1026 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 1190 1199 1186 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1234 1235 1230 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
The characterized hNaa15p-hNaa10p hNatA complex interacts with ribosomes [13] and N-terminally acetylates polypeptides with Ser-, Ala-, Thr-, Val- and Gly- N-termini [1]. Analyses of isolated polysomes demonstrated that hNaa16p-FLAG, as well as hNaa15p and hNaa10p, were both present in the polysomal and the soluble fractions (Figure 7) supporting a model where hNaa16p dynamically associates with ribosomes, and is involved in cotranslational Nalpha-terminal acetylation. To assess whether the hNaa16p-hNaa10p complex expresses acetyltransferase activity, we performed in vitro N-terminal acetyltransferase assays using immunoprecipitated hNaa16p-hNaa10p and synthetic oligopeptides as substrates. A synthetic oligopeptide representing an acetylated protein N-terminus in HeLa cells, SESS-, was acetylated in vitro by hNaa16p-hNaa10p, while an oligopeptide representing an N-terminus not acetylated in HeLa cells, SPTP-, carrying an inhibitory Pro in the second position [1], is not efficiently acetylated in vitro (Figure 8). These results suggest that hNaa16p-hNaa10p and hNaa15p-hNaa10p have overlapping substrate specificities, since also the hNaa15p-hNaa10p complex showed a similar in vitro reactivity towards these peptides [1]. It should be noted, however, that in order to properly define the substrate specificity of the hNaa16p-hNaa10p complex, a more comprehensive approach is required.
###end p 27
###begin p 28
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">hNaa16p co-sediments with polysomal fractions in a salt sensitive manner</bold>
hNaa16p co-sediments with polysomal fractions in a salt sensitive manner. Polysomal pellets from HeLa cells expressing hNaa16p-FLAG were resuspended in buffer containing increasing concentrations of KCl. Cell lysate (L), supernatant post first ultracentrifugation (S) and polysomal pellets after KCl treatment were analyzed on SDS-PAGE/Western blotting. The membrane was incubated with anti-FLAG, anti-hNaa15p, anti-hNaa10p, anti-L26 (ribosomal protein) and anti-CytC antibodies. Molecular-mass markers (in kDa) are indicated on the left hand side. Results shown are representative of three independent experiments.
###end p 28
###begin p 29
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N-terminal acetyltransferase activity of the hNaa16p-hNaa10p complex</bold>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10</italic>
###xml 277 286 277 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
N-terminal acetyltransferase activity of the hNaa16p-hNaa10p complex. HeLa cells were transfected with phNAA16-FLAG and phNAA10-V5, and immunoprecipitated with anti-FLAG (+) or a negative control antibody (-). The immunoprecipitated hNaa16p-hNaa10p complex was subjected to an in vitro N-acetylation assay by the addition of acetylation buffer, a synthetic oligopeptide, [14-C]-Acetyl coenzyme A. The radioactivity incorporated into the peptide was determined by scintillation counting. The peptides used are [H]SESSSKSRWGRPVGRRRRPVRVYP [OH] (SESS) and [H]SPTPPLFRWGRPVGRRRRPVRVYP [OH] (SPTP). An equal level of immunoprecipitated material (input enzyme) was verified by Western-blotting analysis. Results are presented as mean +/- SD from three independent experiments.
###end p 29
###begin title 30
###xml 1 7 1 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
hNAA16 knockdown downregulates hNaa10p and induces cell death
###end title 30
###begin p 31
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 611 617 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Previously, we demonstrated that siRNA-mediated knockdown of hNAA10 or hNAA15 induced apoptosis and cell cycle arrest in human cell lines [18]. Using siRNA pools specific for hNAA15 and hNAA16, we knocked down either gene in HeLa cells. Semiquantitative RT-PCR analysis revealed that both siRNA pools specifically reduced the expression of the targeted gene (Figure 9A). Western blotting analysis of cell lysates harvested 72 hours post siRNA-transfection showed, as expected, that only sihNAA15, not sihNAA16, reduced the protein levels of hNaa15p (Figure 9B). On the other hand, all three siRNAs sihNAA15, sihNAA16 and sihNAA10 significantly reduced protein levels of hNaa10p. The dependency of hNaa10p for hNaa15p has previously been described [26,28], but the present results also indicate that a fraction of endogenous hNaa10p depend on hNaa16p for stability, albeit to a lesser extent as compared hNaa15p. This is in agreement with the relative presence of hNaa15p-hNaa10p versus hNaa16p-hNaa10p complexes described above.
###end p 31
###begin p 32
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Knockdown of h<italic>NAA16 </italic>downregulates hNaa10p</bold>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 334 339 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 342 348 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 450 455 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 458 464 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 468 474 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 960 965 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 970 976 962 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 982 988 974 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
Knockdown of hNAA16 downregulates hNaa10p. (A) HeLa cells cultured in 6 cm dishes were transfected with 50 nM unspecific (Ctr), hNAA15 or hNAA16 siRNAs. ZVAD-fmk (5 muM) was added 24 hours post transfection to prevent any induction of apoptosis. After 48 hours total RNA was isolated and processed by RT-PCR with specific primers to hNAA15, hNAA16 and beta-actin. (B) HeLa cells cultured in 6 cm dishes were transfected with 50 nM unspecific (Ctr), hNAA15, hNAA16 or hNAA10 siRNAs. ZVAD-fmk (5 muM) was added 24 and 48 hours post transfection to prevent any induction of apoptosis. After 72 hours cell lysates were analyzed by SDS-PAGE/Western blotting. The membrane was incubated with anti-hNaa10p, anti-hNaa15p and anti-beta-tubulin. Results shown are representative of three independent experiments. Protein levels were quantified using FUJIFILM IR LAS 1000 and Image Gauge 3.45. Protein levels in siCtr (-) samples were set to 1.0 and protein levels in sihNAA15, sihNAA16 or sihNAA10 treated cells were estimated relative to this and normalized to beta-tubulin levels.
###end p 32
###begin p 33
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 242 245 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10A</xref>
###xml 623 629 623 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 693 696 693 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10B</xref>
###xml 816 822 816 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
Knockdown of hNAA10 and hNAA15 induces apoptosis in HeLa cells [18], and in the case of these cells, we demonstrated that hNAA16 knockdown reduced cell viability at comparable levels to hNAA15 knockdown as determined by a WST-1 assay (Figure 10A). In order to investigate this phenotype, we analysed knockdown cells by live microscopy and observed the appearance of dead cells: cells detaching from monolayer had characteristic features of apoptosis (condensation of nucleus, shrinking of cytoplasm, formation of apoptotic bodies). Furthermore, by Hoechst staining we observed a significant increase of pycnotic nuclei in hNAA15 and hNAA16 knockdown cells as compared to control cells (Figure 10B). A similar observation was made using a TUNEL assay to detect DNA fragmentation further supporting that knockdown of hNAA16 induces cell death, most likely apoptosis (Figure 11).
###end p 33
###begin p 34
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Knockdown of h<italic>NAA16 </italic>reduces cell viability</bold>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 394 400 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 404 410 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
Knockdown of hNAA16 reduces cell viability. (A) HeLa cells were transfected with 50 nM unspecific, hNAA15 or hNAA16 siRNAs. Cell viability was determined by WST-1 assay 72 hours post transfection. The viability of the control cells transfected with Ctr siRNA was set to 100%. The mean +/- SD of three parallel experiments was calculated. (B) HeLa cells were transfected with 50 nM unspecific, hNAA15 or hNAA16 siRNAs for 72 hours and analyzed by phase contrast microscopy (PH) to observe cell morphology and Hoechst33342 staining to visualize nuclei.
###end p 34
###begin p 35
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Knockdown of h<italic>NAA16 </italic>induces cell death</bold>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
Knockdown of hNAA16 induces cell death. HeLa cells were transfected with 50 nM unspecific, hNAA15 or hNAA16 siRNAs. Cells were analyzed by TUNEL-assay 72 hours post transfection. In the left column, Hoechst33342 staining visualizes nuclei in blue; in the middle column, TMR-red TUNEL staining visualizes DNA breaks in red; in the right column, Hoechst and TUNEL signals are merged. Neg: negative controls omitting active TUNEL-reaction enzyme.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 785 791 785 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA10 </italic>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1044 1049 1044 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 1052 1058 1052 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 1063 1069 1063 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1077 1082 1077 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT1 </italic>
###xml 1087 1091 1087 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT2</italic>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1148 1154 1148 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 1241 1247 1241 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 1268 1273 1268 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 1323 1329 1323 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 1369 1374 1369 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 1408 1414 1408 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1435 1441 1435 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 1461 1467 1461 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1530 1531 1530 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1556 1562 1556 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1588 1590 1588 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 1661 1667 1661 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 447 452 <span type="species:ncbi:4932">yeast</span>
###xml 755 760 <span type="species:ncbi:9606">human</span>
###xml 779 784 <span type="species:ncbi:4932">yeast</span>
###xml 812 817 <span type="species:ncbi:9606">human</span>
###xml 837 842 <span type="species:ncbi:4932">yeast</span>
###xml 1013 1018 <span type="species:ncbi:10090">mouse</span>
###xml 1038 1043 <span type="species:ncbi:4932">yeast</span>
###xml 1155 1160 <span type="species:ncbi:10090">mouse</span>
###xml 1248 1253 <span type="species:ncbi:10090">mouse</span>
###xml 1505 1510 <span type="species:ncbi:9606">human</span>
Phylogenetic analysis provides strong support for a vertebrate gene duplication resulting in the two copies of the NAA15 gene, possibly followed by loss of the second copy in fish. The presence of hNaa16p specific peptides in four of four parallel anti-hNaa10p immunoprecipitates is a strong indication of the presence of endogenous hNaa16p protein and of the presence of hNaa16p-hNaa10p complexes. Both hNaa15p and hNaa16p are orthologues of the yeast Naa15p. The simultaneous presence of hNaa15p and hNaa16p in anti-hNaa10p immunoprecipitates, and the lack of hNaa16p in anti-hNaa15p immunoprecipitates, indicate that hNaa15p-hNaa10p and hNaa16p-hNaa10p make distinct NatA complexes in the cells. Recently, we also demonstrated the presence of a second human orthologue of the yeast NAA10 gene [17]. Thus, two human orthologues of the yeast Naa10p protein exist, hNaa10p and hNaa11p. However, to date there is no evidence of the presence of endogenous complexes consisting of hNaa11p and hNaa15p or hNaa16p. In mouse, two homologues of yeast NAA15, mNAA15 and mNAA16 (named mNAT1 and mNAT2), were detected at the mRNA level [29]. In this study, mNAA16 (mouse homologue of hNAA16) was found to be expressed at a lower level as compared to mNAA15 (mouse homologue of hNAA15), in agreement with our results suggesting that hNAA15 is the dominant species as compared to hNAA16. Despite the lower abundance of hNAA16 mRNA as compared to hNAA15 mRNA, we find that hNAA16 is generally expressed in a number of human cell lines (Figure 5) and that knockdown of hNAA16 induces apoptosis (Figure 11), thus suggesting an important role for this novel gene. Whether the hNAA16 knockdown phenotype is resulting from lack of N-terminally acetylated hNaa16p-hNaa10p substrates or whether it is coupled to another unknown function of hNaa16p remains to be investigated.
###end p 37
###begin title 38
Conclusion
###end title 38
###begin p 39
###xml 203 208 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
###xml 261 267 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 297 303 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 233 238 <span type="species:ncbi:9606">human</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
In summary, we have identified hNaa16p, a novel hNaa10p interactor. hNaa16p and hNaa10p most likely represent a novel human NatA complex complementing the role of the hNaa15p-hNaa10p complex in protein Nalpha-terminal acetylation in human cells. The fact that hNAA16 is widely expressed and that hNAA16 knockdown induces apoptosis points to hNaa16p as an essential human protein.
###end p 39
###begin title 40
Methods
###end title 40
###begin title 41
Cell culture and transfection
###end title 41
###begin p 42
###xml 138 140 132 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 453 455 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 456 458 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 681 687 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 689 706 683 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT1/NATH/NARG1) </italic>
###xml 711 717 705 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 719 723 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT2</italic>
###xml 724 732 718 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NARG1L) </italic>
###xml 742 747 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 793 798 787 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 775 778 <span type="species:ncbi:9685">Cat</span>
###xml 826 829 <span type="species:ncbi:9685">Cat</span>
###xml 901 904 <span type="species:ncbi:9685">Cat</span>
HEK293 cells (embryonal kidney, ATCC CRL-1573) and HeLa cells (human cervix carcinoma, DSMZ no. ACC 57) were cultured at 37degreesC, 5% CO2 in DMEM supplemented with 10% FBS and 3% l-glutamine. Plasmid transfection was performed using Fugene6 (Roche) according to the manufacturers instructions. Plasmid expressing hNaa16p (NARG1L)-FLAG was purchased from Origene (RC214224; NM_024561). Plasmids expressing hNaa10p-V5 and hNaa11-V5 have been described [13,17]. siRNA transfection was performed using Dharmafect (Dharmacon) according to the instruction manual. Gene specific smart pool siRNAs were purchased from Dharmacon and used at a final concentration of 50 nM to silence the hNAA15 (hNAT1/NATH/NARG1) and hNAA16 (hNAT2/NARG1L) genes: sihNAA15, ON-TARGET plus SMARTpool, Cat. L-012847; sihNAA16, ON-TARGET plus SMARTpool, Cat. L-013336; negative control (siCtr), ON-TARGETplus Non-Targeting Pool, Cat. no D-001810.
###end p 42
###begin p 43
###xml 93 101 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Situ </italic>
###xml 192 198 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 203 209 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
For TUNEL assay, cytospins were prepared and cells were incubated in TUNEL reaction mixture (In Situ Cell Death Detection Kit, TMR red, Roche) for 1 hour at 37degreesC. Negative controls for hNAA15 and hNAA16 knockdown cells were incubated in TUNEL Label reaction without enzyme.
###end p 43
###begin title 44
Immunoprecipitation and Mass Spectrometry
###end title 44
###begin p 45
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 782 784 782 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 1149 1151 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 172 178 <span type="species:ncbi:9986">Rabbit</span>
###xml 967 973 <span type="species:ncbi:9986">rabbit</span>
Immunoprecipitation and Mass Spectrometry were essentially performed as previously described [13], but omitting the crosslinking of antibodies to Protein AG Agarose beads. Rabbit polyclonal peptide specific antibodies against hNaa15p (anti-NATH) and hNaa10p (anti-hARD1) were produced by Biogenes GmBH. The immunogens correspond to amino acids 853-866 of hNaa15p and amino acids 204-217 of hNaa10p. Anti-hNaa10p does not crossreact with hNaa11p since these two proteins are significantly different in the antibody binding region [17]. A Thermofinnigan LCQ Deca XP Plus and an Agilent 1100 Nanoflow hplc were used for microcapillary LC/MS/MS analysis of tryptic peptides. Data analysis utilized SEQUEST [30], Medusa [31] and support vector machine learning [32]. Approximately 5 x 107 HEK293 cells were used per sample. Four samples were immunoprecipitated in parallel using anti-hNaa15p, four samples using anti-hNaa10p and four samples were immunoprecipitated using rabbit Ig (DAKO) as negative controls. Peptides present in the negative controls were subtracted from the peptides present in the anti-hNaa15p and anti-hNaa10p samples using Medusa [31].
###end p 45
###begin title 46
Immunoprecipitation and Western blotting
###end title 46
###begin p 47
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 165 166 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 168 169 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 302 304 301 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 602 604 595 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 1038 1040 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1122 1124 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1054 1060 <span type="species:ncbi:9986">rabbit</span>
###xml 1217 1228 <span type="species:ncbi:3704">Horseradish</span>
###xml 1252 1257 <span type="species:ncbi:10090">mouse</span>
###xml 1267 1273 <span type="species:ncbi:9986">rabbit</span>
Approximately 2 x 106 cells were harvested for each sample. Cells were lysed in 300 mul IPH lysis buffer (50 mM Tris pH 8, 50 mM NaCl, 0.5% NP-40, 5 mM EDTA, 1 mM Na3VO4, 1 mM Pefabloc (Roche)) and incubated for 5 minutes on ice. Cell membranes and organelles were removed by centrifugation at 15700 x g for 30 seconds, and the cell lysate was transferred to a new tube. To remove proteins that bind unspecifically to the agarose beads, Protein A/G Agarose (Santa Cruz) was added, and the lysate was incubated on a roller for 30 minutes at 4degreesC. The beads were removed by centrifugation at 1500 x g for 4 minutes. The cell lysate was then incubated with 2 mug specific antibody on a roller for 1 - 4 hours at 4degreesC, before adding 50 mul Prot A/G Agarose beads. The lysate was then incubated on a roller at 4degreesC for 4 - 10 hours. The beads were collected by centrifuging as above, and washed with 1 x PBS. The supernatant was removed, and the samples were prepared for analysis by SDS-PAGE and Western Blotting as described [21]. Polyclonal rabbit antibodies against hNaa10p and hNaa15p described previously [13], were used at 1:500 dilution, anti-V5 (Invitrogen) at 1:2000, anti-FLAG (Sigma) at 1:2000. Horseradish peroxidase-linked anti-mouse and anti-rabbit were from Amersham Biosciences (Little Chalfont, Bucks., U.K.).
###end p 47
###begin title 48
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 10 15 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sup>
In vitro Nalpha-acetyltransferase assay
###end title 48
###begin p 49
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 154 156 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 310 312 302 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 780 789 763 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 876 878 857 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
HEK293 cells were transfected by plasmids as described above and indicated in Figure 8, harvested and lysed in 300 mul IPH lysis buffer. Typically, 5 x 106 cells were used. 40 mul Protein A/G Agarose (Santa Cruz) was added to the lysates and incubated for one hour at 4degreesC. After centrifugation at 1500 x g for 2 min, the supernatants were collected and incubated for another 2 hours at 4degreesC with anti-FLAG or unspecific antibody (2 mug). The samples were centrifuged as above and 50 mul Protein A/G Agarose was added to the supernatants. After incubation for 16 hours, centrifugation and three times of washing in 2 x PBS and once in acetylation buffer (50 mM Tris-HCl, pH 8.5, 1 mM DTT, 800 muM EDTA, 10 mM Na-butyrate, 10% Glycerol), the samples were subjected to an in vitro acetylation assay. 10 mul peptide (0.5 mM, custom made peptides from Biogenes), 4 mul [14C] Acetyl-CoA (50 muCi, 2.07 GBq/mmol, GE Healthcare) and 250 mul acetylation buffer was added to pellets of Protein A/G-Agarose bound hNaa16p-FLAG-hNaa10p-V5 complexes. The mixture was incubated for 2 hours at 37degreesC with rotation. After centrifugation the supernatant was added to 250 mul SP Sepharose (50% slurry in 0.5 M acetic acid, Sigma) and incubated on a rotor for 5 min. The mixture was centrifuged and the pellet was washed three times with 0.5 M acetic acid and finally with methanol. Radioactivity in the peptide-containing pellet was determined by scintillation counting. All custom made peptides contains 7 unique amino acids at the N-terminus, since these are the major determinants for N-terminal acetylation. The next 17 amino acids are identical to the ACTH peptide (corticotrophin amino acid 1-24) sequence to maintain a positive charge facilitating peptide solubility and effective isolation by cation exchange Sepharose beads. The ACTH derived lysines were replaced by arginines to minimize any potential interference by Nepsilon-acetylation. Peptide sequence information: High mobility group protein A1 (P17096): [H]SESSSKSRWGRPVGRRRRPVRVYP [OH], THO complex subunit 1 (Q96FV9): [H]SPTPPLFRWGRPVGRRRRPVRVYP [OH].
###end p 49
###begin title 50
Isolation of polysomes
###end title 50
###begin p 51
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 599 601 592 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 667 669 659 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
Total ribosome isolation was performed as a modification of previously described methods [33,34]. Approximately 2 x 107 HEK293 cells were used per experiment. Prior to harvesting, cells were treated with 10 mug/ml cycloheximide (CHX) for 5 minutes at 37degreesC. Cells were harvested, and lysed with KCl ribosome lysis buffer (1.1% (w/v) KCl, 0.15% (w/v) triethanolamine, 0.1% (w/v) magnesium acetate, 8.6% (w/v) sucrose, 0.05% (w/v) Na-Deoxycholate, 0.5% (v/v) Triton-X100, 0.25% (v/v) Pefabloc), and incubated on ice for 15 minutes. After removing nucleus and membranes by centrifugation at 400 x g for 10 min, 700 mul cell lysate was ultracentrifuged at 436,000 x g for 25 minutes on a 0.4 ml pillow of 25% sucrose in KCl ribosome lysis buffer using a MLA-130 rotor (Beckman, Geneva, Switzerland). Pellets were resuspended in ribosome lysis buffer with the indicated KCl concentrations, followed by ultracentrifugation as described above. Pellets were resuspended in KCl ribosome lysis buffer, and prepared for analysis by SDS-PAGE and Western blot.
###end p 51
###begin title 52
RNA purification and cDNA synthesis
###end title 52
###begin p 53
###xml 321 324 320 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">15 </sub>
Total RNA was extracted with TRIzol reagent (Invitrogen, San Diego, CA) according to manufacturer's instructions. RNA was subsequently dissolved in DEPC-treated double-distilled water. Single-strand cDNA was synthesized from 1 mug total RNA using Transcriptor Reverse Transcriptase (Roche, Indianapolis, IN) and oligo(dT)15 primer according to the manufacturer's instructions.
###end p 53
###begin title 54
Real-time Quantitative PCR
###end title 54
###begin p 55
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
Relative gene expression levels of hNAA15 and hNAA16 in thyroid cell lines and cell lines from different tissues were determined by real-time quantitative PCR (RT-qPCR).
###end p 55
###begin p 56
###xml 12 18 12 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hNAA16 </italic>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15 </italic>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 337 343 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
###xml 1436 1439 1412 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 1501 1506 1477 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 1529 1534 1505 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16</italic>
###xml 1619 1624 1595 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA15</italic>
###xml 1626 1632 1602 1608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAA16 </italic>
To amplify hNAA15 and hNAA16 cDNA the following primers were used: hNAA15 primer set 1 (forward TTGGCACGTTTATGGCCTTCT and reverse CGTTTCCCTGTAACCCTCAAGA), hNAA15 primer set 2 (forward TGTATGGAGGTATTGGAAGCC and reverse CTCTTCATATCCAGGAGGCAT); hNAA16 primer set 1 (forward TCTTCCAGACATTGTGAGCAAAG and reverse AGGTAGCGTTACGTTTCAGAAAA) and hNAA16 primer set 2 (forward CAAGATGATTCTGTCGAACCCA and reverse AACGCTGCAAGAGTCCATATAC). For data normalization two reference genes were used independently: large ribosomal protein P2, RpLP2 (GeneID: 6181) and RNA polymerase II, RPol2 (GeneID: 5430). Primers for amplification of reference genes were as following: RpLP2 (forward GACCGGCTCAACAAGGTTAT and reverse CCCCACCAGCAGGTACAC); RPol2 (forward GCACCACGTCCAATGACAT and reverse GTGCGGCTGCTTCCATAA). Templates (equal amount of cDNA) and primers were mixed with components from the LightCycler 480 SYBR Green I Master mix kit (Roche Applied Science). Reactions in triplicate were carried out in the LightCycler 480 real-time PCR machine (Roche Applied Science) under the following conditions: initial denaturation at 95degreesC for 5 min, and then 40 cycles of denaturation at 95degreesC for 10 s, annealing at 57degreesC for 10 s, and extension at 72degreesC for 10 s. Melting curves were obtained to examine the purity of amplified products. Absolute quantitation data and CP values were obtained by analysis with LightCycler 480 Software 1.5 by 2nd derivative method. By the use of plasmids encoding hNaa15p (phNAA15-V5His) and hNaa16p (phNAA16-Flag), we could verify the specificity of the primers used. The relative amount of hNAA15/hNAA16 PCR in each sample was normalized to that of RpLP2 PCR and RPol2 independently.
###end p 56
###begin title 57
Alignment and tree building
###end title 57
###begin p 58
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1151 1182 1151 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae NAA15 </italic>
###xml 1227 1228 1227 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1252 1254 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 1151 1175 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Homologues to human hNaa15p and hNaa16p were identified using them to search Ensembl version 38, April 2006 [35]. Ensembl peptide identifiers for hNaa15p and hNaa16p are ENSP00000296543 and ENSP000000368716/ENSP00000310683 respectively. The two identifiers for hNaa16p represent two possible alternative transcripts in the Ensembl genome annotation. Both hNaa15p and hNaa16p are members of Ensembl protein family ENSF00000002142. All the peptide sequences from this family were aligned using Muscle [36] with the default settings. Coding sequence alignments were produced by aligning the coding sequences with reference to the alignment of the corresponding peptide sequences. A tree was built from the coding sequence alignment using MrBayes [37] with different rates for transitions and transversions, and running for 250,000 generations. The first 100,000 generations were discarded as burn-in, after which the likelihood scores had converged. A consensus tree was built from the remaining 150,000 generations by sampling every 100th generation, and summarising as a majority-rule consensus tree. The resultant unrooted tree was rooted by treating Saccharomyces cerevisiae NAA15 (identifier: YDL040C) as an outgroup. Figure 6 was created with iTOL [38].
###end p 58
###begin title 59
List of abbreviations
###end title 59
###begin p 60
###xml 33 38 <span type="species:ncbi:9606">human</span>
ARD1: Arrest defective 1; hNatA: human N-terminal acetyltransferase A; LC: high performance liquid capillary; MS: mass spectrometry; Naa: N alpha acetyltransferase; NAT: N-terminal acetyltransferase.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
TA planned the study, performed the large scale immunoprecipitation experiments and wrote the manuscript draft. DG performed knockdown experiments, phenotype studies and quantitative RT-PCR. DK performed immunoprecipitation and acetyltransferase assays. MB performed the evolutionary analysis and alignments. KKS performed polysome experiments. DA performed the mass spectrometry analysis and peptide data analysis. All authors took part in planning and manuscript preparation. All authors read and approved the final manuscript.
###end p 62
###begin title 63
Supplementary Material
###end title 63
###begin title 64
Additional File 1
###end title 64
###begin p 65
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LC/MS/MS-sequenced peptides identifying hNaa15p and hNaa16p present in quadruplicate hNaa10p affinity extracts</bold>
LC/MS/MS-sequenced peptides identifying hNaa15p and hNaa16p present in quadruplicate hNaa10p affinity extracts. This table lists all peptides uniquely identifying hNaa15p and hNaa16p and those peptides that are common to both proteins present in hNaa10p affinity extracts.
###end p 65
###begin p 66
Click here for file
###end p 66
###begin title 67
Additional File 2
###end title 67
###begin p 68
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of selected Naa15/16p proteins</bold>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona</italic>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 184 193 <span type="species:ncbi:7955">zebrafish</span>
###xml 198 203 <span type="species:ncbi:4932">yeast</span>
Alignment of selected Naa15/16p proteins. This figure is an alignment of Naa15p and Naa16p protein sequences from human, mouse, and opossum, together with their homologues from Ciona, zebrafish and yeast.
###end p 68
###begin p 69
Click here for file
###end p 69
###begin title 70
Acknowledgements
###end title 70
###begin p 71
We thank N. Glomnes and E. Skjelvik for technical assistance. This work was supported by The Norwegian Cancer Society (Grant to JEV), The Locus of Experimental Cancer Research, University of Bergen (Grant to JRL), The Meltzer Foundation (Grant to TA), FUGE and Western Norway Regional Health Authority (Grants to TA and JEV).
###end p 71
###begin article-title 72
###xml 110 115 <span type="species:ncbi:4932">yeast</span>
###xml 120 126 <span type="species:ncbi:9606">humans</span>
Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans
###end article-title 72
###begin article-title 73
Evidence that approximately eighty per cent of the soluble proteins from Ehrlich ascites cells are Nalpha-acetylated
###end article-title 73
###begin article-title 74
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
A comparison of the turnover of alpha-N-acetylated and nonacetylated mouse L-cell proteins
###end article-title 74
###begin article-title 75
Acetylation of Protein N-terminal amino groups structural observations on alpha-amino acetylated proteins
###end article-title 75
###begin article-title 76
Structures of N-terminally acetylated proteins
###end article-title 76
###begin article-title 77
N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins
###end article-title 77
###begin article-title 78
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides
###end article-title 78
###begin article-title 79
ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity
###end article-title 79
###begin article-title 80
###xml 98 103 <span type="species:ncbi:4932">yeast</span>
Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast
###end article-title 80
###begin article-title 81
###xml 17 22 <span type="species:ncbi:4932">yeast</span>
The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways
###end article-title 81
###begin article-title 82
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus
###end article-title 82
###begin article-title 83
###xml 15 20 <span type="species:ncbi:9606">human</span>
Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis
###end article-title 83
###begin article-title 84
###xml 43 48 <span type="species:ncbi:9606">human</span>
Identification and characterization of the human ARD1-NATH protein acetyltransferase complex
###end article-title 84
###begin article-title 85
###xml 22 27 <span type="species:ncbi:9606">human</span>
Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression
###end article-title 85
###begin article-title 86
###xml 17 22 <span type="species:ncbi:9606">Human</span>
Knockdown of the Human N{alpha}-Terminal Acetyltransferase Complex C (hNatC) Leads to p53-Dependent Apoptosis and Aberrant hArl8b Localization
###end article-title 86
###begin article-title 87
Cloning and characterization of hNAT5/hSAN: an evolutionarily conserved component of the NatA protein N-alpha-acetyltransferase complex
###end article-title 87
###begin article-title 88
###xml 72 77 <span type="species:ncbi:9606">human</span>
Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase
###end article-title 88
###begin article-title 89
###xml 26 31 <span type="species:ncbi:9606">human</span>
Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex
###end article-title 89
###begin article-title 90
Analysis of ARD1 function in hypoxia response using retroviral RNA interference
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation
###end article-title 91
###begin article-title 92
The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target?
###end article-title 92
###begin article-title 93
A genome-wide RNAi screen reveals multiple regulators of caspase activation
###end article-title 93
###begin article-title 94
BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences
###end article-title 94
###begin article-title 95
SMART, a simple modular architecture research tool: identification of signaling domains
###end article-title 95
###begin article-title 96
###xml 38 43 <span type="species:ncbi:9606">human</span>
Large-scale proteomic analysis of the human spliceosome
###end article-title 96
###begin article-title 97
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms
###end article-title 97
###begin article-title 98
NATH, a novel gene overexpressed in papillary thyroid carcinomas
###end article-title 98
###begin article-title 99
Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin
###end article-title 99
###begin article-title 100
An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development
###end article-title 100
###begin article-title 101
An Approach to Correlate Tandem Mass-Spectral Data of Peptides with Amino-Acid-Sequences in A Protein Database
###end article-title 101
###begin article-title 102
Use of MEDUSA-based data analysis and capillary HPLC-ion-trap mass spectrometry to examine complex immunoaffinity extracts of RbAp48
###end article-title 102
###begin article-title 103
A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: Support vector machine classification of peptide MS/MS spectra and SEQUEST scores
###end article-title 103
###begin article-title 104
###xml 33 57 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The molecular chaperone Ssb from Saccharomyces cerevisiae is a component of the ribosome-nascent chain complex
###end article-title 104
###begin article-title 105
The characterization of free, cytoskeletal and membrane-bound polysomes in Krebs II ascites and 3T3 cells
###end article-title 105
###begin article-title 106
Ensembl 2006
###end article-title 106
###begin article-title 107
MUSCLE: multiple sequence alignment with high accuracy and high throughput
###end article-title 107
###begin article-title 108
MrBayes 3: Bayesian phylogenetic inference under mixed models
###end article-title 108
###begin article-title 109
Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation
###end article-title 109

